Completed NA INTERVENTIONAL 3-arm NCT03098238

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation (MICROMARK RJ)

Endothelial Microparticules as Biomarker of Antibody-mediated Rejection in Kidney Transplantation

Sponsor: University Hospital, Montpellier

Updated 9 times since 2017 Last updated: Dec 13, 2022 Started: Nov 30, 2017 Primary completion: Jun 4, 2020 Completion: Jun 4, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Renal Transplantation and is currently completed. University Hospital, Montpellier leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Mar 2022 — Jan 2023 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Feb 2020 — Jan 2021 [monthly]

Recruiting NA
Jun 2018 — Feb 2020 [monthly]

Recruiting NA
Nov 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2017 — Nov 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Montpellier

Data source: University Hospital, Montpellier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montpellier, France